Shock Top Announces its Official Craft Beer Sponsorship of University of Missouri Athletics
September 19, 2024 07:12 ET
|
Tilray Brands, Inc.
Shock Top is proud to contribute to the collegiate experience by promoting a culture of inclusivity, support, and pride that transcends the game.
Tilray Medical bringt die Cannabis-Marke Redecan in Australien auf den Markt
September 18, 2024 10:11 ET
|
Tilray Brands, Inc.
NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, ein Geschäftsbereich von Tilray Brands, Inc. („Tilray Brands“) (NASDAQ: TLRY und TSX: TLRY) und ein weltweit führender Anbieter von...
Tilray Medical lance la marque de cannabis Redecan en Australie
September 18, 2024 10:11 ET
|
Tilray Brands, Inc.
NEW YORK, 18 sept. 2024 (GLOBE NEWSWIRE) -- Tilray Medical, une division de Tilray Brands, Inc. ("Tilray Brands") (NASDAQ : TLRY et TSX : TLRY) et leader mondial du cannabis médical, qui permet...
Tilray Medical Launches Redecan Cannabis Brand in Australia
September 18, 2024 07:00 ET
|
Tilray Brands, Inc.
Tilray's EU-GMP Certified Redecan Cannabis Now Available in Australia with Medical Prescription.
Tilray Brands Completes Acquisition of Atwater Brewery From Molson Coors Beverage Company
September 12, 2024 16:05 ET
|
Tilray Brands, Inc.
Atwater Brewery from Molson Coors joins Tilray Brands’ beverage portfolio which includes leading craft beer, spirits, and non-alcohol beverage brands.
Breckenridge Brewery Unveils Oktoberfest Brew and Hosts 28th Annual Oktoberfest Festival: A Weekend of Live Music, Traditional German Cuisine, and Tasty Brews in Breckenridge, Colorado
September 12, 2024 07:00 ET
|
Tilray Brands, Inc.
Breckenridge Oktoberfest Presented by Breckenridge Brewery Brings a Weekend of Live Music, Traditional German Cuisine, and Tasty Brews
Tilray Medical Supports Scientific Study on Fibromyalgia With Positive Outcomes: Effectiveness of Cannabinoids Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms
September 09, 2024 07:00 ET
|
Tilray Brands, Inc.
LISBON, Portugal, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the...
Tilray Medical unterstützt wissenschaftliche Studie zu Fibromyalgie Mit positiven Ergebnissen: Wirksamkeit der Cannabinoid-Behandlung von Schmerzen und anderen mit Fibromyalgie verbundenen Symptomen
September 09, 2024 07:00 ET
|
Tilray Brands, Inc.
LISSABON, Portugal, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, ein Geschäftsbereich von Tilray Brands, Inc. („Tilray“) (Nasdaq: TLRY; TSX: TLRY) und ein weltweit führender Anbieter von...
Tilray Medical participe à une étude scientifique sur la fibromyalgie avec des résultats positifs : efficacité du traitement aux cannabinoïdes de la douleur et d’autres symptômes associés à la fibromyalgie
September 09, 2024 07:00 ET
|
Tilray Brands, Inc.
LISBONNE, Portugal, 09 sept. 2024 (GLOBE NEWSWIRE) -- Tilray Medical, division de Tilray Brands, Inc. (« Tilray ») (Nasdaq : TLRY ; TSX : TLRY) et leader mondial du cannabis thérapeutique, qui...
Tilray Brands Completes Acquisition of Craft Beer Brands and Breweries from Molson Coors Beverage Company
September 03, 2024 10:33 ET
|
Tilray Brands, Inc.
This acquisition of further strengthens Tilray's leadership position in the U.S. craft beer market as the 5th largest craft brewer in the country.